Literature DB >> 11564379

Rheumatic manifestations of pituitary tumors.

S Stavrou1, D L Kleinberg.   

Abstract

Pituitary tumors may cause rheumatologic problems as a result of under production or overproduction of one pituitary hormone. Excessive growth hormone causes destruction of cartilage by a direct action. Facial and acral changes and arthralgias may be some of the first symptoms of acromegaly. The arthritis associated with acromegaly is often devastating. Carpal tunnel syndrome is very common in patients with acromegaly. Adrenocorticotropin (ACTH) has indirect effects via the action of glucocorticoid on bones, muscles, and the immune system. Proximal muscle weakness is a characteristic feature of Cushing's syndrome. Patients with Cushing's syndrome commonly have osteopenia and osteoporosis that lead to an increase in bone fractures. Avascular necrosis is associated with exogenous steroid administration. The effects of too much glucocorticoid or too rapid withdrawal can be severe. Gonadotropins act via the gonadal steroids and protect bone mass from loss. Prolactin is less involved in rheumatologic disease; the data for which are limited in humans. Pituitary tumors can have manifestations similar to rheumatologic disorders and should be included in the differential diagnosis of these diseases.

Entities:  

Mesh:

Year:  2001        PMID: 11564379     DOI: 10.1007/s11926-996-0018-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  65 in total

1.  Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency.

Authors:  G A McGauley
Journal:  Acta Paediatr Scand Suppl       Date:  1989

2.  Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.

Authors:  B A Bengtsson; S Edén; I Ernest; A Odén; B Sjögren
Journal:  Acta Med Scand       Date:  1988

3.  Acromegalic arthropathy.

Authors:  R Bluestone; E G Bywaters; M Hartog; P J Holt; S Hyde
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

4.  The pathology of median neuropathy in acromegaly.

Authors:  P J Jenkins; S A Sohaib; S Akker; R R Phillips; K Spillane; J A Wass; J P Monson; A B Grossman; G M Besser; R H Reznek
Journal:  Ann Intern Med       Date:  2000-08-01       Impact factor: 25.391

5.  A decade of pituitary microsurgery. The Herbert Olivecrona lecture.

Authors:  C B Wilson
Journal:  J Neurosurg       Date:  1984-11       Impact factor: 5.115

6.  Endogenous iridocyclitis relieved during treatment with bromocriptine.

Authors:  L P Hedner; G Bynke
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

7.  Psoriasis in association with prolactinoma: three cases.

Authors:  M Sánchez Regaña; P Umbert Millet
Journal:  Br J Dermatol       Date:  2000-10       Impact factor: 9.302

8.  Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study.

Authors:  R F Dons; P Rosselet; B Pastakia; J Doppman; P Gorden
Journal:  Clin Endocrinol (Oxf)       Date:  1988-05       Impact factor: 3.478

9.  Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.

Authors:  P Jungers; M Dougados; C Pélissier; F Kuttenn; F Tron; P Lesavre; J F Bach
Journal:  Arthritis Rheum       Date:  1982-06

10.  Effect of hyperthyroidism and its treatment on bone mineral content.

Authors:  S H Toh; B C Claunch; P H Brown
Journal:  Arch Intern Med       Date:  1985-05
View more
  1 in total

1.  Diagnosis and treatment of acromegaly complications.

Authors:  A Giustina; F F Casanueva; F Cavagnini; P Chanson; D Clemmons; L A Frohman; R Gaillard; K Ho; P Jaquet; D L Kleinberg; S W J Lamberts; G Lombardi; M Sheppard; C J Strasburger; M L Vance; J A H Wass; S Melmed
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.